AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | – | 5 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q1 2022 | $233,000 | -68.2% | 325,232 | +0.5% | 0.00% | – |
| Q4 2021 | $732,000 | +9.9% | 323,769 | +39.9% | 0.00% | – |
| Q3 2021 | $666,000 | +75.3% | 231,365 | +130.0% | 0.00% | – |
| Q2 2021 | $380,000 | -34.5% | 100,591 | -41.3% | 0.00% | – |
| Q1 2021 | $580,000 | -67.0% | 171,345 | -72.7% | 0.00% | -100.0% |
| Q4 2020 | $1,760,000 | +5.2% | 628,546 | -5.7% | 0.00% | 0.0% |
| Q3 2020 | $1,673,000 | -41.7% | 666,811 | +215.8% | 0.00% | -50.0% |
| Q2 2020 | $2,868,000 | +369.4% | 211,181 | +161.9% | 0.00% | +100.0% |
| Q1 2020 | $611,000 | -7.4% | 80,619 | -22.8% | 0.00% | – |
| Q4 2019 | $660,000 | +33.3% | 104,419 | -17.4% | 0.00% | – |
| Q3 2019 | $495,000 | -1.2% | 126,344 | +21.8% | 0.00% | – |
| Q2 2019 | $501,000 | -39.7% | 103,734 | +2.2% | 0.00% | -100.0% |
| Q1 2019 | $831,000 | +57.7% | 101,469 | +6.5% | 0.00% | 0.0% |
| Q4 2018 | $527,000 | +95.2% | 95,286 | +212.0% | 0.00% | – |
| Q3 2018 | $270,000 | -41.0% | 30,539 | -33.5% | 0.00% | – |
| Q2 2018 | $458,000 | -9.5% | 45,926 | -13.3% | 0.00% | – |
| Q1 2018 | $506,000 | -23.8% | 52,988 | +18.6% | 0.00% | -100.0% |
| Q4 2017 | $664,000 | -6.7% | 44,690 | +23.3% | 0.00% | 0.0% |
| Q3 2017 | $712,000 | +111.9% | 36,239 | +54.9% | 0.00% | – |
| Q2 2017 | $336,000 | +60.0% | 23,401 | +15.9% | 0.00% | – |
| Q4 2016 | $210,000 | +14.8% | 20,182 | -0.6% | 0.00% | – |
| Q3 2016 | $183,000 | -24.4% | 20,304 | -37.4% | 0.00% | – |
| Q2 2016 | $242,000 | +86.2% | 32,443 | +125.3% | 0.00% | – |
| Q1 2016 | $130,000 | -27.4% | 14,401 | +3.7% | 0.00% | – |
| Q4 2015 | $179,000 | +68.9% | 13,892 | +26.5% | 0.00% | – |
| Q3 2015 | $106,000 | -80.4% | 10,986 | -79.1% | 0.00% | -100.0% |
| Q2 2015 | $541,000 | +75.1% | 52,552 | +89.4% | 0.00% | – |
| Q1 2015 | $309,000 | +34.9% | 27,751 | +40.9% | 0.00% | – |
| Q4 2014 | $229,000 | – | 19,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |